Sean David to Cost-Benefit Analysis
This is a "connection" page, showing publications Sean David has written about Cost-Benefit Analysis.
Connection Strength
0.015
-
A cost-effectiveness analysis of genetic testing of the DRD2 Taq1A polymorphism to aid treatment choice for smoking cessation. Nicotine Tob Res. 2008 Jan; 10(1):231-40.
Score: 0.015